Page last updated: 2024-10-15

phosphoserine and Tuberous Sclerosis

phosphoserine has been researched along with Tuberous Sclerosis in 2 studies

Phosphoserine: The phosphoric acid ester of serine.

Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roux, PP1
Ballif, BA1
Anjum, R1
Gygi, SP1
Blenis, J1
Shah, OJ1
Hunter, T1

Other Studies

2 other studies available for phosphoserine and Tuberous Sclerosis

ArticleYear
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Sep-14, Volume: 101, Issue:37

    Topics: Amino Acid Sequence; Animals; Cell Line; Enzyme Activation; Humans; MAP Kinase Signaling System; Mod

2004
Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis.
    Molecular and cellular biology, 2006, Volume: 26, Issue:17

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Culture Techniques; Cells, Cultured; Humans; Ins

2006